Wall Street analyst estimates for Ingevity Corporation (NGVT): consensus price target and buy/hold/sell recommendations.
Ingevity Corporation (NGVT) is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. The company's reach extends across North America, the Asia Pacific region, Europe, the Middle East, Africa, and South America. Its business operations are organized into two principal divisions: Performance Materials and Performance Chemicals.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 10 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 13 |
| Avg rating (−2 sell to +2 buy) | 0.77 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-04 | $1.56 | ||
| 2026-07-29 | $1.74 | $1.33 | +30.8% |
| 2026-05-06 | $1.15 | $0.84 | +36.9% |
| 2026-02-25 | $0.58 | $0.67 | -12.8% |
| 2025-11-05 | $1.31 | $0.68 | +92.6% |
| 2025-08-04 | $1.39 | $1.02 | +36.3% |
| 2025-05-05 | $0.99 | $0.74 | +33.8% |
| 2025-02-18 | $0.95 | $0.29 | +227.6% |
Valuation Ratios
| P/E Ratio | 50.56 |
| Price / Book | 55.46 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $908.3M | $972.4M | $1.13B | $1.29B | $1.22B | $1.39B | $1.67B | $1.69B | $1.41B | $1.17B |
| Cost of Revenue | $633.9M | $643.4M | $716.8M | $810.9M | $750.6M | $878.7M | $1.10B | $1.22B | $951.7M | $706.1M |
| Gross Profit | $274.4M | $329.0M | $416.8M | $482.0M | $465.5M | $512.8M | $570.1M | $471.9M | $454.7M | $461.5M |
| Research & Development | $7.6M | $19.8M | $21.5M | $19.7M | $22.6M | $26.3M | $30.3M | $31.8M | $28.1M | $28.4M |
| Selling, General & Admin | $114.0M | $106.4M | $132.4M | $163.1M | $149.4M | $179.3M | $198.8M | $183.7M | $166.7M | $171.2M |
| Operating Expenses | $114.0M | $126.2M | $153.9M | $182.8M | $465.5M | $205.6M | $229.1M | $215.5M | $194.8M | $199.6M |
| Operating Income | $160.4M | $202.8M | $262.9M | $327.9M | 0 | $307.2M | $341.0M | $256.4M | $259.9M | $261.9M |
| EBITDA | $199.2M | $243.1M | $319.8M | $412.9M | $382.4M | $324.4M | $440.2M | $206.0M | -$329.5M | $37.4M |
| Interest Expense | $19.3M | $18.1M | $33.2M | $55.8M | $47.1M | $51.7M | $61.8M | $93.3M | $97.8M | $77.1M |
| Pre-tax Income | $87.0M | $174.8M | $221.8M | $227.9M | $235.1M | $162.8M | $269.6M | -$10.1M | -$535.6M | -$142.1M |
| Income Tax | $42.6M | $29.8M | $40.0M | $44.2M | $53.7M | $44.7M | $58.0M | -$4.7M | -$105.3M | $8.2M |
| Net Income | $35.2M | $126.3M | $169.1M | $183.7M | $181.4M | $118.1M | $211.6M | -$5.4M | -$430.3M | -$167.1M |
| EPS | $0.83 | $3.00 | $4.03 | $4.39 | $4.39 | $2.97 | $5.50 | -$0.15 | -$11.85 | -$4.61 |
| EPS (Diluted) | $0.83 | $2.97 | $3.97 | $4.35 | $4.37 | $2.95 | $5.50 | -$0.15 | -$11.85 | -$4.61 |
| Shares Outstanding (Diluted) | 42.3 M | 42.5 M | 42.6 M | 42.2 M | 41.5 M | 40.1 M | 38.5 M | 36.5 M | 36.3 M | 36.2 M |
Price
| Price | $74.32 (closing price, October 30, 2026) |
| Market Cap | $2.6B |
| Exchange | NYSE |
| Country | US |
Related companies: IOSP · SKE · AAUC · CC · OLN · ASH · KWR
Explore sector: Basic Materials · Chemicals - Specialty
More sections of NGVT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks